View printer-friendly version
« Back
May 25, 2009 5:05 p.m.
Teva to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fifth Annual Strategic Decision Conference 2009

Jerusalem, Israel, May 25, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the Sanford C. Bernstein & Co., LLC Twenty-Fifth Annual Strategic Decisions Conference 2009 with Shlomo Yanai, President and Chief Executive Officer, presenting on Wednesday, May 27, 2009, in New York.


What: Teva Presentation at the Sanford C. Bernstein & Co., LLC Twenty-Fifth Annual Strategic Decisions Conference 2009

Who: Shlomo Yanai, President and Chief Executive Officer, Teva Pharmaceutical
Industries Ltd.

When: Wednesday, May 27, 2009 at 3:00 p.m. ET

Where: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TEVA&item_id=2184606
or http://www.tevapharm.com/financial/

How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.


About Teva
Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 20 pharmaceutical companies in the world and is the world's leading generic pharmaceutical company. The Company develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients, as well as animal health pharmaceutical products. Over 80 percent of Teva's sales are in North America and Europe.